Tango Therapeutics to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

Tango Therapeutics, Inc. (NASDAQ: TNGX) will have its President and CEO, Barbara Weber, M.D., present at the Jefferies London Healthcare Conference on November 14, 2023, at 1:00 PM GMT. The presentation will be available via live webcast and will be archived on the company's website for 90 days.

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 1:00 PM GMT.

A live webcast of the presentation will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Andrew Vulis
Argot Partners
tango@argotpartners.com

Media Contact:
Amanda Galgay
SVP, Corporate Communications, Tango Therapeutics
media@tangotx.com

FAQ

What is the date of the Jefferies London Healthcare Conference presentation for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The presentation is scheduled for November 14, 2023.

Who will be presenting at the conference for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

Barbara Weber, M.D., the President and Chief Executive Officer of Tango Therapeutics, will be presenting.

Where can I watch the presentation of Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The presentation will be available via live webcast on the company's website under the 'Events & Presentations' tab on the 'Investors' page.

How long will the webcast of the presentation be available for viewing on the company's website for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The webcast will be archived on the company's website for 90 days following the presentation.